Pharmaceutical tablet

- Glaxo Group Limited
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

The file of this patent contains at least one drawing executed in color. Copies of this patent with color drawings will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 is a front perspective view of a pharmaceutical tablet showing our new design;

FIG. 2 is a top view thereof;

FIG. 3 is a bottom view thereof;

FIG. 4 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 5 is a cross-sectional view through section 55 of FIG. 1;

FIG. 6 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 7 is a top view thereof;

FIG. 8 is a bottom view thereof;

FIG. 9 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 10 is a cross-sectional view through section 1010 of FIG. 6;

FIG. 11 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 12 is a top view thereof;

FIG. 13 is a bottom view thereof;

FIG. 14 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 15 is a cross-sectional view through section 1515 of FIG. 11;

FIG. 16 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 17 is a top view thereof;

FIG. 18 is a bottom view thereof;

FIG. 19 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 20 is a cross-sectional view through section 2020 of FIG. 16;

FIG. 21 is a front perspective view of am alternate embodiment of the design of FIG. 1;

FIG. 22 is a top view thereof;

FIG. 23 is a bottom view thereof;

FIG. 24 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 25 is a cross-sectional view through section 2525 of FIG. 21;

FIG. 26 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 27 is a top view thereof;

FIG. 28 is a bottom view thereof;

FIG. 29 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 30 is a cross-sectional view through section 3030 of FIG. 26;

FIG. 31 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 32 is a top view thereof;

FIG. 33 is a bottom view thereof;

FIG. 34 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 35 is a cross-sectional view through section 3535 of FIG. 31;

FIG. 36 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 37 is a top view thereof;

FIG. 38 is a bottom view thereof;

FIG. 39 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 40 is a cross-sectional view through section 4040 of FIG. 36;

FIG. 41 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 42 is a top view thereof;

FIG. 43 is a bottom view thereof;

FIG. 44 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 45 is a cross-sectional view through section 4545 of FIG. 41;

FIG. 46 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 47 is a top view thereof;

FIG. 48 is a bottom view thereof;

FIG. 49 is a front view thereof, with the left side, right side and rear views thereof being identical thereto; and,

FIG. 50 is a cross-sectional view through section 5050 of FIG. 46.

The different styles of shading in FIGS. 16–20 depict a color contrast, and are not indicative of any specific color.

Claims

The ornamental design for a pharmaceutical tablet, as shown and described.

Referenced Cited
U.S. Patent Documents
1419618 June 1922 Deming
1580576 April 1926 Weidner
2102885 December 1937 Carroll
2340037 January 1944 Zipper
3048526 August 1962 Boswell
3620759 November 1971 Maddox
3702653 November 1972 Motten
D235215 May 1975 Larson
D258091 January 27, 1981 Reed et al.
4376111 March 8, 1983 Tovey
D269718 July 12, 1983 Tovey
D269721 July 12, 1983 Tovey
D269722 July 12, 1983 Tovey
D274846 July 24, 1984 Eoga
D283649 April 29, 1986 Casberg
4601896 July 22, 1986 Nugent
D285363 August 26, 1986 Tovey
D286085 October 7, 1986 Tovey
4643731 February 17, 1987 Eckenhoff
4735805 April 5, 1988 Ni et al.
4883182 November 28, 1989 Hughes
D376643 December 17, 1996 Hatton et al.
D420464 February 8, 2000 Binstock et al.
D520635 May 9, 2006 Bonny et al.
D530814 October 24, 2006 Bonny et al.
D535741 January 23, 2007 Stawski et al.
D556946 December 4, 2007 Seum et al.
D564086 March 11, 2008 Nielsen et al.
Patent History
Patent number: D601689
Type: Grant
Filed: Nov 9, 2006
Date of Patent: Oct 6, 2009
Assignee: Glaxo Group Limited (Middlesex)
Inventors: Wlodek Karolak (Mississauga), Helen Anne Willy (Harlow)
Primary Examiner: Ian Simmons
Assistant Examiner: Charles D Hanson
Attorney: Nixon & Vanderhye P.C.
Application Number: 29/268,559
Classifications
Current U.S. Class: Tablet Or Caplet (1) (D24/101)